cTnI (5C7HC)
| $162.00 | |
| V00306-1 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $162.00 | |
| V00306-1 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Specificity |
Specific to Human cTnI. No cross-reactivity with human cTnT |
| Clone ID | 5C7HC |
| Epitope | 40-50 within cTnI protein |
| Isotype | Recombinant human IgG1 for 5C7HC. |
| Subclass | Recombinant Human IgG1 |
| Host Species | Recombinant Human IgG1 |
| Antigen Species | Human |
| Conjugation | Unconjugated | |||||||||||||||||||||||||||||||||||||||
| Production | Cultured in vitro under conditions free from animal-derived components | |||||||||||||||||||||||||||||||||||||||
| Purification | Protein A/G affinity column | |||||||||||||||||||||||||||||||||||||||
| Concentration | ≥ 2mg/ml | |||||||||||||||||||||||||||||||||||||||
| Formulation | 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% ProClin 300. | |||||||||||||||||||||||||||||||||||||||
| Storage | For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles. | |||||||||||||||||||||||||||||||||||||||
| Product Stability |
|
|||||||||||||||||||||||||||||||||||||||
| Note | GenScript can customize this product per customer's request including product size, buffer components, etc. | |||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||
| Target Background | Cardiac Troponin I (cTnI) is synthesized in cardiac muscle and forms a structural complex with Troponin T and C. Its concentration in blood increases after the onset of chest pain and maintains peak for a couple of weeks. The cTnI protein is considered as useful diagnosis marker for acute myocardial infarction (AMI). |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.